Brainstorm Cell Theraputc (BCLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -23,253 | -15,561 | -9,927 | -5,027 | -13,948 |
| Depreciation Amortization | 164 | 114 | 77 | 44 | 110 |
| Accounts receivable | 690 | 938 | 648 | 1,449 | -238 |
| Other Working Capital | 11,053 | 6,871 | 5,117 | 3,811 | 431 |
| Other Operating Activity | 99 | -331 | -258 | -1,112 | 1,257 |
| Operating Cash Flow | $-11,247 | $-7,969 | $-4,343 | $-835 | $-12,388 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 6,089 | 6,088 | 4,547 | 3,135 | -849 |
| PPE Investments | -473 | -127 | -25 | -4 | -369 |
| Investing Cash Flow | $5,616 | $5,961 | $4,522 | $3,131 | $-1,218 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 2,064 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 3,161 | 3,161 | 5 | N/A | 12,065 |
| Financing Cash Flow | $5,225 | $3,161 | $5 | $N/A | $12,065 |
| Beginning Cash Position | 942 | 942 | 942 | 942 | 2,483 |
| End Cash Position | 536 | 2,095 | 1,126 | 3,238 | 942 |
| Net Cash Flow | $-406 | $1,153 | $184 | $2,296 | $-1,541 |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,247 | -7,969 | -4,343 | -835 | -12,388 |
| Capital Expenditure | -473 | -127 | -25 | -4 | -369 |
| Free Cash Flow | -11,720 | -8,096 | -4,368 | -839 | -12,757 |